REQUEST A DEMO
Total
USD $0.00
Search more companies

Genveon Ilac A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Genveon Ilac Sanayi Ve Ticaret Anonim Sirketi Profile Updated: March 05, 2026
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English Download a sample report

Genveon Ilac A.S. is based in Turkiye, with the head office in Istanbul. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was first established on September 19, 2007. There are currently 821 (2025) people employed by Genveon Ilac A.S.. There was a net sales revenue increase of 292.56% reported in Genveon Ilac A.S.’s latest financial highlights for 2023. There was a total growth of 307.78% in Genveon Ilac A.S.’s total assets over the same period. In 2023, Genveon Ilac A.S.’s net profit margin decreased by 13.45%.

Headquarters
K:14 No:4 Maslak Mahallesi Sumer Sokak Maslak Office Building-mob Maslak Sariyer
Istanbul; Marmara; Postal Code: 34485

Contact Details: Purchase the Genveon Ilac A.S. report to view the information.

Website: http://www.genveon.com.tr

Basic Information
Total Employees:
Purchase the Genveon Ilac A.S. report to view the information.
Financial Auditors:
Purchase the Genveon Ilac A.S. report to view the information.
Incorporation Date:
September 19, 2007
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Genveon Ilac A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
292.56%
Total Operating Revenue
292.56%
Operating Profit
63.59%
Net Profit/Loss for the Period
63.59%
Total Assets
307.78%
Total Equity
492.39%
Operating Profit Margin
-13.45%
Net Profit Margin
-13.45%
Return on Equity (ROE)
-50.78%
Quick Ratio
-0.52%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?